India’s metabolic therapy market is transforming post-semaglutide patent expiry, shifting to a competitive, volume-driven model. With significant price drops and increased launches, demand is surging among millions needing obesity management. Broader specialist adoption and a growing prescriber base are fueling this expansion, promising substantial market growth.
US stocks today: US stocks end lower for the day and week as chip selloff broadens
Wall Street declined as AI-driven chip stocks extended losses, triggering broader risk-off sentiment. Semiconductor shares saw sharp weekly declines, while energy stocks gained on rising
July 17, 2026